US2003022313A1PendingUtilityA1

Novel neuronal cell growth factor

Priority: Apr 8, 1996Filed: Aug 20, 2002Published: Jan 30, 2003
Est. expiryApr 8, 2016(expired)· nominal 20-yr term from priority
C07K 14/71A61K 38/00C12N 5/0619
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A novel neuronal cell growth factor, neuronal-activity regulated pentraxin, Narp, is provided, as well as polynucleotides encoding Narp. Narp is useful for induction of dendritic neurite outgrowth as well as promotion of neuronal migration. Methods for treatment of subjects having a neuronal cell disorder, utilizing Narp of the invention, are also provided.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . An isolated polynucleotide encoding the Narp polypeptide of  claim 1 .  
     
     
         2 . The polynucleotide of  claim 4 , wherein the Narp nucleotide sequence is selected from the group consisting of: 
 a) SEQ ID NO:1(FIG. 1), wherein T can also be U;    b) a polynucleotide encoding all or a portion of the amino acid sequence of SEQ ID NO:2 (FIG. 1);    c) a polynucleotide which hybridizes to a) or b).    
     
     
         3 . A recombinant expression vector comprising a polynucleotide sequence according to  claim 4 .  
     
     
         4 . The vector of  claim 6 , wherein the vector is a plasmid.  
     
     
         5 . The vector of  claim 6 , wherein the vector is a virus.  
     
     
         6 . A host cell stably transformed with the vector of  claim 6 .  
     
     
         7 . A method for producing a neuronal cell growth factor comprising culturing host cells of claim  9  under conditions which allow expression of the polynucleotide sequence and isolating the growth factor.

Join the waitlist — get patent alerts

Track US2003022313A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.